Zepbound
Active Ingredient(s): Tirzepatide FDA Approved: * November 8, 2023Pharm Company: * ELI LILLY AND CO Category: Diabetes * May have multiple approval dates, manufacturers, or labelers.
1 Discussion
Dosage List
Zepbound 2.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-0152
Labeler:
Eli Lilly and Company
Zepbound 5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-0243
Labeler:
Eli Lilly and Company
Zepbound 7.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1214
Labeler:
Eli Lilly and Company
Zepbound 10 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1340
Labeler:
Eli Lilly and Company
Zepbound 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1423
Labeler:
Eli Lilly and Company
Zepbound 15 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2002
Labeler:
Eli Lilly and Company
Zepbound 15 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2457
Labeler:
Eli Lilly and Company
Zepbound 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2460
Labeler:
Eli Lilly and Company
Zepbound 10 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2471
Labeler:
Eli Lilly and Company
Zepbound 7.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2484
Labeler:
Eli Lilly and Company
Related Brands
Drugs with the same active ingredients
Popular Topics